Tag: User consent

Browse our exclusive articles!

Italian DPA’s Recent Actions Regarding AI Bots and EU Data Protection: ChatGPT

Recently, the Italian Data Protection Authority (Garante) ordered the shutdown of ChatGPT, a popular Artificial Intelligence (AI) chatbot, due to its alleged violation of the EU's General Data Protection Regulation (GDPR). With this, organizations that use the chatbot are left wondering if this is a sign of the EU’s commitment towards innovative AI technologies. OpenAI, the company behind ChatGPT, received a "ToDo List" from the Garante to improve the chatbot and ensure data security. The order has been met with contrasting responses from organizations developing AI and other disruptive technologies. In light of this, the European Data Protection Board (EDPB) is expected to issue a statement on the issue.

Associate Dean of Oregon State’s Crucial Take on the ChatGPT Crisis

. Discover the implications of the recent ChatGPT crisis and how Oregon State University's associate dean is advocating forbetter protections for user data. Get an inside look at the data protection regulations being proposed, allowing individuals greater control over their data. Learn more about Oregon State University and their renowned research achievements.

OpenAI Complies with Privacy Rules: ChatGPT Returns to Italy, Confirms Watchdog

OpenAI has been subject to the Italian privacy watchdogs for its AI ChatGPT technology. Garante determined certain requirements for the software to return to Italian users, which OpenAI happily agreed to embrace. The company attempts to make user-data processing secure and transparent, as well as set age-restricted access for the system. Get the latest insight on AI technology with the expertise from game developer John Carmack, CTO at OpenAI.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img